ACTA PHARM SIN B 润色咨询

Acta Pharmaceutica Sinica B

出版年份:暂无数据 年文章数:894 投稿命中率: 开通期刊会员,数据随心看

出版周期:暂无数据 自引率:3.5% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊简介

期刊简介
GetPortalImpactFactorByIdResp(projectId=1, id=aea313193, cover=https://img.medsci.cn/images/journal/cover/2021/iGD_202109271314013290.jpg, fullname=Acta Pharmaceutica Sinica B, abbr=ACTA PHARM SIN B, pyear=暂无数据, frequence=null, articleNumbers=894, citedSelf2015=3.5, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均2.24月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=2211-3835, greenSci=https://www.greensci.net/search?kw=2211-3835, scijournal=https://www.scijournal.org/impact-factor-of-ACTA-PHARM-SIN-B.shtml, medsciHotlightString=null, medsciHotlightRealtime=14.257, medsciHotlight=15.452, medsciHotlight5year=12.7139, citescore=12.5, hIndex=51, impactFactor=14.5, orgnization=Elsevier BV, orgnizationUrl=, country=Netherlands, countryCn=荷兰, isOa=1, isOaString=是, sciScie=SCIE, bigclassCas=医学 1区[Top], smallclassCas=, website=https://www.journals.elsevier.com/acta-pharmaceutica-sinica-b/, websiteHits=9680, guideForAuthor=http://www.elsevier.com/journals/acta-pharmaceutica-sinica-b/2211-3835/guide-for-authors, guideForAuthorHits=1549, submitWebsite=https://www.evise.com/profile/api/navigate/APSB, submitWebsiteHits=4946, content=<p style="box-sizing: border-box; margin: 0px 0px 0.25em; padding: 0px; vertical-align: baseline; line-height: 1.625rem; text-rendering: optimizeLegibility; max-width: inherit;"><a href="http://www.yxxb.com.cn:8081/apsb/EN/volumn/current.shtml" rel="external" style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline; line-height: inherit; transition: all 111ms ease-out; background-image: initial; background-position: 0px 0px; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; word-break: break-word; word-wrap: break-word; border-bottom: none !important;">Acta Pharmaceutica Sinica B</a> (APSB) is a bimonthly journal, in English, which publishes significant original research articles, rapid communications and high quality reviews of recent advances in all areas of pharmaceutical sciences — including pharmacology, pharmaceutics, medicinal chemistry, natural products, pharmacognosy, pharmaceutical analysis and pharmacokinetics.</p><p style="box-sizing: border-box; margin: 0px 0px 0.25em; padding: 0px; vertical-align: baseline; line-height: 1.625rem; text-rendering: optimizeLegibility; max-width: inherit;"><a href="http://www.yxxb.com.cn:8081/apsb/EN/volumn/current.shtml" rel="external" style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline; line-height: inherit; transition: all 111ms ease-out; background-image: initial; background-position: 0px 0px; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; word-break: break-word; word-wrap: break-word; border-bottom: none !important;">APSB</a> is a series of journal of Acta Pharmaceutica Sinica, which was founded in 1953, indexed in Chemical Abstracts, Index Medicus, SciFinder Scholar, Biological Abstracts, International Pharmaceutical Abstracts, Cambridge Scientific Abstracts, Current Bibliography on Science and Technology, etc. It sponsored by <a href="http://www.imm.ac.cn/" rel="external" style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline; line-height: inherit; transition: all 111ms ease-out; background-image: initial; background-position: 0px 0px; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; word-break: break-word; word-wrap: break-word; border-bottom: none !important;">Insititute of Materia Medica, Chineses Acedemy of Medical Sciences</a> and <a href="http://www.cpa.org.cn/Index.html" rel="external" style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline; line-height: inherit; transition: all 111ms ease-out; background-image: initial; background-position: 0px 0px; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; word-break: break-word; word-wrap: break-word; border-bottom: none !important;">Chinese Pharmaceutical Association</a>, production and hosting by Elsevier B. V.</p><p bdsfid="307" style="word-wrap: break-word; margin: 0px 0px 15px; padding: 0px; border: 0px; vertical-align: baseline; line-height: 1.7 !important;">从Acta Pharmaceutica Sinica B(APSB)官方获知,该刊已被SCIE收录,收录内容从2015年第1期开始!近日APSB将从ESCI库移至SCIE库。</p><p bdsfid="308" style="word-wrap: break-word; margin: 0px 0px 15px; padding: 0px; border: 0px; vertical-align: baseline; line-height: 1.7 !important;">《药学学报》英文刊Acta Pharmaceutica Sinica B创刊于2011年,由中国药学会和中国医学科学院药物研究所共同主办,由《药学学报》编辑部和Elsevier联合出版,双月刊,主编:蒋建东。是我国首部被SCI收录的药学综合性学术期刊!</p><p bdsfid="309" style="word-wrap: break-word; margin: 0px 0px 15px; padding: 0px; border: 0px; vertical-align: baseline; line-height: 1.7 !important;">2018年第一个影响因子有望超过6分</p>, totalCites=12975, brief=ACTA PHARM SIN B杂志医学行业,暂不明确子行业的级别不明杂志, articleType=本刊接收类型不明, medsciHeat=<span style="color: #0000ff;">蓝</span>, medsciComment=虽然从国际上看,影响力一般。另外,大家关注整体偏低了一些,但是这是中国本土SCI期刊,取得这样成绩也是相当不错的,希望大家多关注支持!, medsciExplanation=MedSci期刊指数是根据中国科研工作者(含医学临床,基础,生物,化学等学科)对SCI杂志的认知度,熟悉程度,以及投稿的量等众多指标综合评定而成。当然,具体的,您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=aea313193'>投稿经验系统</a>”,进行综合判断,这更是大家的实战经验,值得分享和参考。<br> 注意,上述MedSci期刊指数采用MedSci专利技术,由计算机系统自动计算,并给出建议,存在不准确的可能,仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=27394, tagName=药理学, createdHits=9), ImpactFactorTagDto(id=10874, tagName=药理, createdHits=4), ImpactFactorTagDto(id=112, tagName=药学, createdHits=3), ImpactFactorTagDto(id=11018, tagName=生物, createdHits=2), ImpactFactorTagDto(id=41472, tagName=药剂学, createdHits=1), ImpactFactorTagDto(id=41263, tagName=毒理学, createdHits=1), ImpactFactorTagDto(id=2964, tagName=分子生物学, createdHits=1), ImpactFactorTagDto(id=134, tagName=药物分析, createdHits=1), ImpactFactorTagDto(id=43309, tagName=药物制剂, createdHits=1), ImpactFactorTagDto(id=465981, tagName=新药研究, createdHits=1), ImpactFactorTagDto(id=21539, tagName=肺血管, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2018, citescore=6.88), GetImpactFactorCiteScoreListResponse(year=2019, citescore=10.5), GetImpactFactorCiteScoreListResponse(year=2020, citescore=12.5)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=16.09), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=18.217), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=18.099), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=13.277), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=14.257)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Pharmacology, Toxicology and Pharmaceutics - General Pharmacology, Toxicology and Pharmaceutics , rank=1/63)], totalJcrAreaList=[], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2211-3835[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=Acta Pharmaceutica Sinica B[ta], article_number=296, article_number_cn=263, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)
期刊名称
ACTA PHARM SIN B/Acta Pharmaceutica Sinica B
ISSN
2211-3835
影响指数话题
预警等级
MedSci期刊指数
14.257 (MedSci实时期刊指数) | 12.7139 (5年期刊指数)
CiteScore值
12.5
h-index
51
h5-median
暂无数据
出版社/管理机构
杂志由 Elsevier BV 出版或管理
出版国家/地区
Netherlands 荷兰
出版周期
暂无数据
出版年份
暂无数据
是否OA
被收录情况
SCIE
JCR分区
暂无数据
中科院分区
大类:医学 1区[Top]
小类: